It looks like the clinical data has been pretty po
Post# of 35
Posted On: 03/25/2014 11:50:14 PM
Re: Stock_Tracker #3
It looks like the clinical data has been pretty positive thus far for their TLC-3000 laser applications
Up to 100% cancer cell kill at very low concentrations (< 0.8µM)
More effective at killing cancer cells than already approved therapies: (668,000x ALA, 198x Photofrin)
Survival of mice up to 20 months (50 human years) after a single Theralase PDT treatment
Up to 100% cancer cell kill at very low concentrations (< 0.8µM)
More effective at killing cancer cells than already approved therapies: (668,000x ALA, 198x Photofrin)
Survival of mice up to 20 months (50 human years) after a single Theralase PDT treatment
(0)
(0)Theralase Technologies (TLTFF) Stock Research Links
Scroll down for more posts ▼